Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
54.51
-0.63 (-1.14%)
At close: Apr 10, 2026, 4:00 PM EDT
53.45
-1.06 (-1.94%)
After-hours: Apr 10, 2026, 7:16 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.86 billion as of April 10, 2026. Its market cap has increased by 236.71% in one year.
Market Cap
3.86B
Enterprise Value
2.42B
1-Year Change
236.71%
Ranking
Category
Stock Price
$54.51
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.86B, an increase of 603.61%. That is a compound annual growth rate of 84.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 3.86B | -19.69% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amicus Therapeutics | 4.54B |
| Corcept Therapeutics | 4.49B |
| Crinetics Pharmaceuticals | 4.15B |
| Ligand Pharmaceuticals | 4.10B |
| Spyre Therapeutics | 4.07B |
| Viking Therapeutics | 4.05B |
| NewAmsterdam Pharma Company | 4.03B |
| ACADIA Pharmaceuticals | 3.85B |